The global electrolarynx market was valued at $409.5 million in 2021 and is projected to reach $703.0 million by 2031, registering a CAGR of 5.5% from 2022 to 2031. An electronic larynx (electrolarynx) is battery-powered equipment that generates sound so that a person can speak. There are various makes and models, but they are typically the size of a small electric razor. When a person wants to talk, this little, battery-operated gadget is put right on the neck, beneath the chin. The electrolarynx produces a vibration that is sent via the skin to the throat when a person presses a button on the device. With the mouth, tongue, lips, and teeth, the patient forms this sound into words.
The artificial larynx device allows individuals who have lost their voice to adjust and save several sound frequency parameters to produce improved speech. Voice restoration devices are most utilized after a laryngectomy, in which the whole voice box, known as the larynx, is permanently removed, separating the windpipe and food pipe.
The key factors that drive the growth of the market are the rise in the prevalence of laryngeal cancer and the surge in the consumption of alcohol and tobacco are the major factors drive the electrolarynx market. For instance, according to the report published by the American Cancer Society, it has been estimated for laryngeal cancer in the U. S. for 2022 that, about 12,470 new cases of laryngeal cancer (9,820 in men and 2,650 in women) were recorded in about 3,820 people (3,070 men and 750 women) died from laryngeal cancer. Furthermore, the increase in the cases of respiratory papilloma which is caused by the human papillomavirus (HPV) is usually benign (non-cancerous). These growths can lead to vocal cord damage and airway problems, which increases the demand for electrolarynx devices hence propelling the growth of the market. Moreover, the high adoption of these medical devices and continuously investing in R&D by numerous key players for the launch of innovative and technologically advanced electrolarynx devices are anticipated to fuel the market growth.
However, the high cost of electrolarynx devices hampers market growth. Conversely, rising cases of hypopharyngeal cancer, the emerging healthcare market in developing countries, and low-income countries lacking access to basic healthcare, and an increase in the risk of laryngeal cancer are expected to provide a lucrative opportunity for the growth of the market during the forecast period.
The electrolarynx market is segmented on the basis of type, application, end-user, and region. By type, the market is segmented into external batteries and built-in batteries. By application, it is bifurcated into laryngeal cancer and speech rehabilitation. By end user, the market is segmented into hospitals, ambulatory surgical centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the electrolarynx market share in 2021 and is anticipated to remain dominant during the forecast period. The electrolarynx market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of laryngeal cancer. Moreover, an increase in the number of people consuming alcohol and tobacco and a rise in the demand for electrolarynx devices are contributing to the market growth in the region. Furthermore, an increasing number of key players in this region are involved in R&D activities for the development of technologically advanced medical devices, and the initiatives being undertaken by various organizations to spread awareness and reduce the prevalence rate of hypopharyngeal cancer through innovative research are expected to fuel the market growth.
Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, the rapidly growing population, various lifestyle changes such as the high rate of people consuming alcohol and tobacco, rising incidence of laryngeal cancer, improvement in the quality of diagnosis, and increasing patient affordability are set to drive the market in the Asia-Pacific region. This helps several market players to invest in Asia-Pacific countries, which in turn will further contribute to the growth of the market.
The key players that operate in the electrolarynx market are Atos Medical, Amplicord, Fountain Head Marketing, Inc., Medline Industries, Nu Vois, Labaex, InHealth Technologies, Romet, Servona GmbH, Luminaud, and Ultravoice.
The artificial larynx device allows individuals who have lost their voice to adjust and save several sound frequency parameters to produce improved speech. Voice restoration devices are most utilized after a laryngectomy, in which the whole voice box, known as the larynx, is permanently removed, separating the windpipe and food pipe.
The key factors that drive the growth of the market are the rise in the prevalence of laryngeal cancer and the surge in the consumption of alcohol and tobacco are the major factors drive the electrolarynx market. For instance, according to the report published by the American Cancer Society, it has been estimated for laryngeal cancer in the U. S. for 2022 that, about 12,470 new cases of laryngeal cancer (9,820 in men and 2,650 in women) were recorded in about 3,820 people (3,070 men and 750 women) died from laryngeal cancer. Furthermore, the increase in the cases of respiratory papilloma which is caused by the human papillomavirus (HPV) is usually benign (non-cancerous). These growths can lead to vocal cord damage and airway problems, which increases the demand for electrolarynx devices hence propelling the growth of the market. Moreover, the high adoption of these medical devices and continuously investing in R&D by numerous key players for the launch of innovative and technologically advanced electrolarynx devices are anticipated to fuel the market growth.
However, the high cost of electrolarynx devices hampers market growth. Conversely, rising cases of hypopharyngeal cancer, the emerging healthcare market in developing countries, and low-income countries lacking access to basic healthcare, and an increase in the risk of laryngeal cancer are expected to provide a lucrative opportunity for the growth of the market during the forecast period.
The electrolarynx market is segmented on the basis of type, application, end-user, and region. By type, the market is segmented into external batteries and built-in batteries. By application, it is bifurcated into laryngeal cancer and speech rehabilitation. By end user, the market is segmented into hospitals, ambulatory surgical centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the electrolarynx market share in 2021 and is anticipated to remain dominant during the forecast period. The electrolarynx market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of laryngeal cancer. Moreover, an increase in the number of people consuming alcohol and tobacco and a rise in the demand for electrolarynx devices are contributing to the market growth in the region. Furthermore, an increasing number of key players in this region are involved in R&D activities for the development of technologically advanced medical devices, and the initiatives being undertaken by various organizations to spread awareness and reduce the prevalence rate of hypopharyngeal cancer through innovative research are expected to fuel the market growth.
Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, the rapidly growing population, various lifestyle changes such as the high rate of people consuming alcohol and tobacco, rising incidence of laryngeal cancer, improvement in the quality of diagnosis, and increasing patient affordability are set to drive the market in the Asia-Pacific region. This helps several market players to invest in Asia-Pacific countries, which in turn will further contribute to the growth of the market.
The key players that operate in the electrolarynx market are Atos Medical, Amplicord, Fountain Head Marketing, Inc., Medline Industries, Nu Vois, Labaex, InHealth Technologies, Romet, Servona GmbH, Luminaud, and Ultravoice.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the electrolarynx market analysis from 2021 to 2031 to identify the prevailing electrolarynx market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the electrolarynx market segmentation assists in determining the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes an analysis of the regional as well as global electrolarynx market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Built-in Battery
- External Battery
By Application
- Laryngeal Cancer
- Speech Rehabilitation
By End user
- Hospitals
- Ambulatory Surgical Centers
- others
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Ultravoice Limited
- Inhealth Technologies
- Griffin Labs
- Servona GmbH
- Labex Trade
- AMPLICORD DI GABRIELLA SALVATORE
- Romet Limted
- Nu-Vois, LLC
- Andreas Fahl Medizintechnik - Vertrieb GmbH
- Atos Medical AB
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: ELECTROLARYNX MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Built-in Battery
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 External Battery
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: ELECTROLARYNX MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Laryngeal Cancer
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Speech Rehabilitation
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: ELECTROLARYNX MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Ambulatory Surgical Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4 others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: ELECTROLARYNX MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End user
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Type
7.2.5.1.3 Market size and forecast, by Application
7.2.5.1.4 Market size and forecast, by End user
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Type
7.2.5.2.3 Market size and forecast, by Application
7.2.5.2.4 Market size and forecast, by End user
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Type
7.2.5.3.3 Market size and forecast, by Application
7.2.5.3.4 Market size and forecast, by End user
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End user
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Type
7.3.5.1.3 Market size and forecast, by Application
7.3.5.1.4 Market size and forecast, by End user
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Type
7.3.5.2.3 Market size and forecast, by Application
7.3.5.2.4 Market size and forecast, by End user
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Type
7.3.5.3.3 Market size and forecast, by Application
7.3.5.3.4 Market size and forecast, by End user
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Type
7.3.5.4.3 Market size and forecast, by Application
7.3.5.4.4 Market size and forecast, by End user
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Type
7.3.5.5.3 Market size and forecast, by Application
7.3.5.5.4 Market size and forecast, by End user
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Type
7.3.5.6.3 Market size and forecast, by Application
7.3.5.6.4 Market size and forecast, by End user
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End user
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Type
7.4.5.1.3 Market size and forecast, by Application
7.4.5.1.4 Market size and forecast, by End user
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Type
7.4.5.2.3 Market size and forecast, by Application
7.4.5.2.4 Market size and forecast, by End user
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Type
7.4.5.3.3 Market size and forecast, by Application
7.4.5.3.4 Market size and forecast, by End user
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Type
7.4.5.4.3 Market size and forecast, by Application
7.4.5.4.4 Market size and forecast, by End user
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Type
7.4.5.5.3 Market size and forecast, by Application
7.4.5.5.4 Market size and forecast, by End user
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Type
7.4.5.6.3 Market size and forecast, by Application
7.4.5.6.4 Market size and forecast, by End user
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End user
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Type
7.5.5.1.3 Market size and forecast, by Application
7.5.5.1.4 Market size and forecast, by End user
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Type
7.5.5.2.3 Market size and forecast, by Application
7.5.5.2.4 Market size and forecast, by End user
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Type
7.5.5.3.3 Market size and forecast, by Application
7.5.5.3.4 Market size and forecast, by End user
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Type
7.5.5.4.3 Market size and forecast, by Application
7.5.5.4.4 Market size and forecast, by End user
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Ultravoice Limited
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Inhealth Technologies
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Griffin Labs
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Servona GmbH
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Labex Trade
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 AMPLICORD DI GABRIELLA SALVATORE
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Romet Limted
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Nu-Vois, LLC
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Andreas Fahl Medizintechnik - Vertrieb GmbH
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Atos Medical AB
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Electrolarynx Market,' the Electrolarynx Market Size was valued at $409.5 million in 2021 and is estimated to reach $703.0 million by 2031, growing at a CAGR of 5.5% from 2022 to 2031.Electrolarynx is a medical device. It is the size of about a small electric razor that generates vibration when placed under the skin of the face or neck. An electrolarynx device is one method for voice rehabilitation. This method involves a handheld external device that generates vibration when placed on the skin of the neck or face. The vibrating sound created by the electrolarynx is then shaped by the tongue and lips and converted into understandable speech. It should be noted that the voice produced with the electrolarynx has a somewhat'robotic' sound, which can be modulated to some extent.
The Electrolarynx Market Trends are an increase in the incidence of laryngeal cancer as well as rising demand for electrolarynx devices. Moreover, a rise in the cases of human papillomavirus infection and a surge in the consumption of alcohol and tobacco, which increase the chance of laryngeal cancer, boosts the growth of the market. For instance, according to the report published by Cancer Net in 2020, it has been reported that around 12,470 adults (9,820 men and 2,650 women) in the U.S. are diagnosed with laryngeal cancer. Thus, the rise in the number of people suffering from laryngeal cancer increases the demand for electrolarynx devices, which propels the Electrolarynx Market Growth. Furthermore, the increasing hypopharyngeal cancer population in India and China has increased the demand for technologically advanced electrolarynx devices, which will provide lucrative opportunities for the growth of the market.
On the basis of type, the electrolarynx market is segmented into external batteries and built-in batteries. In 2021, the built-in battery segment accounted for the largest share of the market. The dominance of this segment can be attributed to the increasing prevalence of laryngeal cancer and the benefits provided by built-in battery electrolarynx devices as the batteries of these types of devices are rechargeable batteries that can be charged again after being discharged, thereby increasing the demand for built-in battery electrolarynx devices.
On the basis of application, the electrolarynx market is segmented into laryngeal cancer and speech rehabilitation. In 2021, the laryngeal cancer segment accounted for the largest share of the market. The dominance of this segment can be attributed to the rise in the number of populations and the surge in the consumption of alcohol and tobacco which causes laryngeal cancer.
By end user the Electrolarynx Industry is segmented into hospitals, ambulatory surgical centers, and others, the hospital's segment exhibited the highest growth in 2021, and is anticipated to lead during the forecast period, owing to an increase in the number of patients visiting hospitals for the surgical procedure due to rise in the prevalence of cancer and also, hospitals are better equipped to handle any post-operative complications and they include facilities for physical rehabilitation post surgeries are the key factors that drive the growth of the market in upcoming years.
North America accounted for a majority of the electrolarynx market share in 2021 and is anticipated to remain dominant during the forecast period. Owing to the high adoption rate of technologically advanced electrolarynx devices for laryngeal cancer, the increase in the healthcare expenditure and presence of major key players in the country, and the strategies they adopt for the development of voice restoration products such as electrolarynx devices.
Asia-Pacific is expected to register the fastest CAGR during the forecast period. The market growth in the Asia-Pacific region is supplemented by the rising consumption of alcohol and tobacco, highly populated countries along with a high rate of active smokers and a high prevalence of hypopharyngeal cancer. In addition, the increasing patient awareness about the availability of technologically advanced voice restoration devices and the presence of high unmet medical needs in these nations, especially in countries such as India and China, are expected to further drive the market growth.
The key players that operate in the electrolarynx market are Atos Medical, Amplicord, Andreas Fahl Medizintechnik, Griffin Laboratories, NU-Vois, Labaex Trade, InHealth Technologies, Romet, SERVONA GmbH, and ULTRAVOICE Limited.
Key findings of the study
By type, the built-in battery segment was the highest contributor to the market in 2021.By application, the laryngeal cancer segment was the highest contributor to the market in 2021.
By end users, the hospital's segment dominated the market in 2021 and is expected to continue this trend during the forecast period.
By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Ultravoice Limited
- Inhealth Technologies
- Griffin Labs
- Servona GmbH
- Labex Trade
- Amplicord Di Gabriella Salvatore
- Romet Limted
- Nu-Vois, LLC
- Andreas Fahl Medizintechnik - Vertrieb GmbH
- Atos Medical Ab
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 190 |
| Published | October 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 409.5 million |
| Forecasted Market Value ( USD | $ 703 million |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
